These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 23686414

  • 1. Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.
    O'Dell JR, Curtis JR, Mikuls TR, Cofield SS, Bridges SL, Ranganath VK, Moreland LW, TEAR Trial Investigators.
    Arthritis Rheum; 2013 Aug; 65(8):1985-94. PubMed ID: 23686414
    [Abstract] [Full Text] [Related]

  • 2. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, Bridges SL, Zhang J, McVie T, Howard G, van der Heijde D, Cofield SS, TEAR Investigators.
    Arthritis Rheum; 2012 Sep; 64(9):2824-35. PubMed ID: 22508468
    [Abstract] [Full Text] [Related]

  • 3. Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.
    Curtis JR, McVie T, Mikuls TR, Reynolds RJ, Navarro-Millán I, O'Dell J, Moreland LW, Bridges SL, Ranganath VK, Cofield SS.
    J Rheumatol; 2013 May; 40(5):572-8. PubMed ID: 23588939
    [Abstract] [Full Text] [Related]

  • 4. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.
    Navarro-Millán I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL, Chen L, Cofield SS, Dell'Italia LJ, Moreland LW, O'Dell JR, Paulus HE, Curtis JR.
    Arthritis Rheum; 2013 Jun; 65(6):1430-8. PubMed ID: 23460074
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis.
    Chen XX, Dai Q, Huang AB, Wu HX, Zhao DB, Li XF, Hu SX, Yang NP, Tao Y, Xu JH, Jiang LD, Bao CD.
    Clin Rheumatol; 2013 Jan; 32(1):99-108. PubMed ID: 23053688
    [Abstract] [Full Text] [Related]

  • 6. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
    Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, Pedersen R, Koenig AS, Freundlich B, Combination of Methotrexate and Etanercept in Early Rheumatoid Arthritis Trial Group.
    Arthritis Rheum; 2010 Mar; 62(3):674-82. PubMed ID: 20187135
    [Abstract] [Full Text] [Related]

  • 7. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E, CSP 551 RACAT Investigators.
    N Engl J Med; 2013 Jul 25; 369(4):307-18. PubMed ID: 23755969
    [Abstract] [Full Text] [Related]

  • 8. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
    Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, Singh A, Pedersen RD, Koenig AS, Freundlich B.
    Lancet; 2008 Aug 02; 372(9636):375-82. PubMed ID: 18635256
    [Abstract] [Full Text] [Related]

  • 9. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).
    Dougados MR, van der Heijde DM, Brault Y, Koenig AS, Logeart IS.
    J Rheumatol; 2014 Oct 02; 41(10):1922-34. PubMed ID: 25128520
    [Abstract] [Full Text] [Related]

  • 10. The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis.
    Pope JE, Haraoui B, Thorne JC, Vieira A, Poulin-Costello M, Keystone EC.
    Ann Rheum Dis; 2014 Dec 02; 73(12):2144-51. PubMed ID: 23979914
    [Abstract] [Full Text] [Related]

  • 11. The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis.
    Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.
    J Rheumatol; 2016 Jul 02; 43(7):1268-77. PubMed ID: 27252426
    [Abstract] [Full Text] [Related]

  • 12. Etanercept for the treatment of rheumatoid arthritis.
    Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.
    Cochrane Database Syst Rev; 2013 May 31; 2013(5):CD004525. PubMed ID: 23728649
    [Abstract] [Full Text] [Related]

  • 13. Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate.
    Koyama Y, Shiraishi H, Ohta T, Uchino A.
    Mod Rheumatol; 2012 Feb 31; 22(1):100-8. PubMed ID: 21706263
    [Abstract] [Full Text] [Related]

  • 14. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis.
    Emery P, Genovese MC, van Vollenhoven R, Sharp JT, Patra K, Sasso EH.
    J Rheumatol; 2009 Jul 31; 36(7):1429-41. PubMed ID: 19369462
    [Abstract] [Full Text] [Related]

  • 15. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
    Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR.
    Arthritis Rheum; 2008 May 31; 58(5):1310-7. PubMed ID: 18438851
    [Abstract] [Full Text] [Related]

  • 16. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
    Curtis JR, Palmer JL, Reed GW, Greenberg J, Pappas DA, Harrold LR, Kremer JM.
    Arthritis Care Res (Hoboken); 2021 Aug 31; 73(8):1114-1124. PubMed ID: 32374918
    [Abstract] [Full Text] [Related]

  • 17. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.
    J Clin Rheumatol; 2014 Jan 31; 20(1):25-33. PubMed ID: 24356474
    [Abstract] [Full Text] [Related]

  • 18. Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial.
    Charles-Schoeman C, Yin Lee Y, Shahbazian A, Wang X, Elashoff D, Curtis JR, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, Paulus H, O'Dell J, Bathon J, Louis Bridges S, Reddy ST.
    Arthritis Rheumatol; 2017 Jan 31; 69(1):46-57. PubMed ID: 27483410
    [Abstract] [Full Text] [Related]

  • 19. The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study).
    Zhao J, Zhou W, Wu Y, Ji P, Yang L, Yan X, Zhang Z.
    BMC Med Inform Decis Mak; 2021 Mar 04; 21(1):83. PubMed ID: 33663487
    [Abstract] [Full Text] [Related]

  • 20. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.
    Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF.
    Arthritis Rheumatol; 2017 May 04; 69(5):953-963. PubMed ID: 27992691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.